Skip to content
The Policy VaultThe Policy Vault

Oxymorphone Hydrochloride Extended-Release — CareFirst (Caremark)

Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate

Initial criteria

  • Reserve for use only in patients for whom alternative treatment options (non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain
  • Not indicated as an as-needed (prn) analgesic